Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment-Reference-Cited by-同舟云学术

Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment

Published:2020-02-25 Issue:3 Volume:11 Page:756-767
ISSN:2190-5991
Container-title:Journal of Cachexia, Sarcopenia and Muscle
language:en
Short-container-title:Journal of Cachexia, Sarcopenia and Muscle

Author:

Hagens Eliza R.C.¹^ORCID,Feenstra Minke L.¹,Egmond Maarten A.²,Laarhoven Hanneke W.M.³^ORCID,Hulshof Maarten C.C.M.⁴^ORCID,Boshier Piers R.⁵⁶,Low Donald E.⁵^ORCID,Berge Henegouwen Mark I.¹^ORCID,Gisbertz Suzanne S.¹^ORCID

Affiliation:

1. Department of SurgeryAmsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam Amsterdam The Netherlands

2. Department of RehabilitationAmsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam Amsterdam The Netherlands

3. Department of Medical OncologyAmsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam Amsterdam The Netherlands

4. Department of RadiotherapyAmsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam Amsterdam The Netherlands

5. Department of Thoracic Surgery and Thoracic OncologyVirginia Mason Medical Center Seattle WA USA

6. Department of Surgery and CancerImperial College London London UK

Publisher

Wiley

Subject

Physiology (medical),Orthopedics and Sports Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcsm.12540

Reference56 articles.

1. Techniques and short-term outcomes for total minimally invasive Ivor Lewis esophageal resection in distal esophageal and gastroesophageal junction cancers: pooled data from six European centers

2. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial

3. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

4. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

5. Does neoadjuvant chemoradiotherapy increase survival in patients with resectable oesophageal cancer?

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of body composition, grip strength, and physical performance on clinical outcomes for locally advanced gastric cancer during neoadjuvant chemotherapy: A prospective cohort study;Nutrition;2024-09

2. A cross-sectional survey study on the correlation analysis of nutritional status and intestinal flora in patients with esophageal cancer;Frontiers in Nutrition;2024-07-12

3. CT-based muscle and adipose measurements predict prognosis in patients with digestive system malignancy;Scientific Reports;2024-06-06

4. Prevalence and clinical outcomes of sarcopenia in patients with esophageal, gastric or colorectal cancers receiving preoperative neoadjuvant therapy: A meta-analysis;Asia-Pacific Journal of Oncology Nursing;2024-04

5. Nomograms combining computed tomography-based body composition changes with clinical prognostic factors to predict survival in locally advanced cervical cancer patients;Journal of X-Ray Science and Technology;2024-03-27